Pollack SJ - Search Results

1

Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.

Atack JR, Broughton HB, Pollack SJ. Atack JR, et al. Among authors: pollack sj. Trends Neurosci. 1995 Aug;18(8):343-9. doi: 10.1016/0166-2236(95)93926-o. Trends Neurosci. 1995. PMID: 7482796 Review.

2

Structure and mechanism of inositol monophosphatase.

Atack JR, Broughton HB, Pollack SJ. Atack JR, et al. Among authors: pollack sj. FEBS Lett. 1995 Mar 13;361(1):1-7. doi: 10.1016/0014-5793(95)00063-f. FEBS Lett. 1995. PMID: 7890024 Free article. Review.

3

Mechanism of inositol monophosphatase, the putative target of lithium therapy.

Pollack SJ, Atack JR, Knowles MR, McAllister G, Ragan CI, Baker R, Fletcher SR, Iversen LL, Broughton HB. Pollack SJ, et al. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5766-70. doi: 10.1073/pnas.91.13.5766. Proc Natl Acad Sci U S A. 1994. PMID: 8016062 Free PMC article.

4

Structural analysis of inositol monophosphatase complexes with substrates.

Bone R, Frank L, Springer JP, Pollack SJ, Osborne SA, Atack JR, Knowles MR, McAllister G, Ragan CI, Broughton HB, et al. Bone R, et al. Among authors: pollack sj. Biochemistry. 1994 Aug 16;33(32):9460-7. doi: 10.1021/bi00198a011. Biochemistry. 1994. PMID: 8068620

5

Probing the role of metal ions in the mechanism of inositol monophosphatase by site-directed mutagenesis.

Pollack SJ, Knowles MR, Atack JR, Broughton HB, Ragan CI, Osborne S, McAllister G. Pollack SJ, et al. Eur J Biochem. 1993 Oct 1;217(1):281-7. doi: 10.1111/j.1432-1033.1993.tb18244.x. Eur J Biochem. 1993. PMID: 8223565 Free article.

6

The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor.

Pollack S, Young L, Bilsland J, Wilkie N, Ellis S, Hefti F, Broughton H, Harper S. Pollack S, et al. Mol Pharmacol. 1999 Jul;56(1):185-95. doi: 10.1124/mol.56.1.185. Mol Pharmacol. 1999. PMID: 10385700

7

Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.

Pollack SJ, Lewis H. Pollack SJ, et al. Curr Opin Investig Drugs. 2005 Jan;6(1):35-47. Curr Opin Investig Drugs. 2005. PMID: 15675602 Review.

8

Sulphated compounds attenuate beta-amyloid toxicity by inhibiting its association with cells.

Sadler II, Smith DW, Shearman MS, Ragan CI, Tailor VJ, Pollack SJ. Sadler II, et al. Among authors: pollack sj. Neuroreport. 1995 Dec 29;7(1):49-53. Neuroreport. 1995. PMID: 8742414

9

Small molecule Trk receptor agonists and other neurotrophic factor mimetics.

Pollack SJ, Harper SJ. Pollack SJ, et al. Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):59-80. doi: 10.2174/1568007023339490. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769635 Review.

10

The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors.

Wilkie N, Wingrove PB, Bilsland JG, Young L, Harper SJ, Hefti F, Ellis S, Pollack SJ. Wilkie N, et al. Among authors: pollack sj. J Neurochem. 2001 Sep;78(5):1135-45. doi: 10.1046/j.1471-4159.2001.00504.x. J Neurochem. 2001. PMID: 11553687 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters